ICD-10 Coding for Lung Adenocarcinoma(C34.0, C34.1, C34.1M)
Comprehensive guide to ICD-10 coding for lung adenocarcinoma, including primary and metastatic codes, documentation requirements, and common pitfalls.
Complete code families applicable to Lung Adenocarcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung | Use when adenocarcinoma is confirmed in the upper lobe of the lung. |
|
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung | Use for adenocarcinoma confirmed in the middle lobe of the right lung. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLung Adenocarcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lung Adenocarcinoma.
Non-specific documentation of lung cancer
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to lack of specificity.
Mitigation
Always document the specific lobe and laterality., Use biopsy and imaging findings to guide documentation.
Using C34.9 when specific lobe is known
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases specificity and accuracy of clinical data.
Mitigation
Use the specific code for the lobe involved (e.g., C34.1 for upper lobe).
Specificity in Tumor Location
Impact
Audits may focus on the specificity of tumor location documentation.
Mitigation
Ensure all documentation includes specific lobe and laterality.